Russia introduces novel cancer therapy
Russia has announced the registration of a new medication to treat certain advanced cases of breast and ovarian cancer in pregnant women carrying BRCA1/2 mutations. This drug aims to provide an additional treatment option for patients with these conditions, enhancing the potential for effective therapy and progress in the treatment of these types of cancers.
articleDetails.fontSize.sizeحجم النص
تنويه: هذا ملخص تم إنشاؤه بواسطة الذكاء الاصطناعي
comments.heading